Location: San Francisco, CA
CIK: 0001977548 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $279M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SEPN | SEPTERNA INC | 100,300 | $2.41M | 0.9% | $26.51 | 0.0% | COM | 81734D104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 40,230 | $1.461M | 0.5% | $49.21 | 0.0% | COM | 22663K107 |
| TRVI | TREVI THERAPEUTICS INC | 50,000 | $597K | 0.2% | $10.94 | 0.0% | COM | 89532M101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 153,000 (+7.7%) | $112M (-6.4%) | 40.1% | $483.33 | — | SPONSORED ADR | 04016X101 |
| CYTK | CYTOKINETICS INC | 180,000 (+7.9%) | $11.86M (+11.9%) | 4.3% | $57.98 | +11.1% | COM NEW | 23282W605 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1,227,200 (+23.7%) | $107M (+0.5%) | 38.3% | $65.99 | +55.8% | COM | 76243J105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | 401,395 | $13.97M | 5.0% | $72.48 | -46.5% | — | 218352102 |
| CORT | CORCEPT THERAPEUTICS INC | 128,300 | $4.465M | 1.6% | $72.48 | -46.5% | CALL | 218352102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 286,661 (-36.7%) | $18.33M (-49.0%) | 6.6% | $58.37 | +26.8% | COM | 254604101 |
| RVMD | REVOLUTION MEDICINES INC | 262,539 (-29.0%) | $25.53M (-13.4%) | 9.2% | $42.98 | +139.7% | COM | 76155X100 |